US FDA approves Cue Health's at-home COVID test
June 6 (Reuters) - The U.S. Food and Drug Administration on Tuesday approved Cue Health's HLTH.O at-home COVID-19 test, the first coronavirus test to get marketing authorization using a traditional premarket review, the agency said. (Reporting by Raghav Mahobe in Bengaluru; Editing by Krishna Chandra Eluri) ((Raghav.Mahobe@thomsonreuters.com;))
Recent news on Cue Health
See all newsNASDAQ RESUMED AT 09:40 AM
NASDAQ TRADE HALT REASON NOT AVAILABLE AT 04:00 AM
U.S. STOCKS ON THE MOVE-Salesforce, Birkenstock, Kohls Corp
U.S. STOCKS ON THE MOVE-Marathon Oil, Faraday Future, Semler Scientific
Brief: Cue Health Inc On May 16, Terminated Its Loan And Security Agreement, Dated June 30, 2022